BMY: Bristol-Myers Squibb Company

46.87 USD 0.10 (0.21%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de BMY de hoy ha cambiado un -0.21%. En este caso, el precio mínimo en el mercado ha alcanzado 46.72, mientras que el máximo ha alcanzado 47.39.

Siga la dinámica de la pareja de divisas Bristol-Myers Squibb Company. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

BMY News

Seeking Alpha 13:00 I'm Buying Dividend Giants At Huge Discounts
Investing 11:47 Prothena stock maintains Neutral rating after restructuring plan
Investing 20:57 William Blair initiates Contineum stock with outperform on MS drug potential
Seeking Alpha 17:24 IHE: Healthcare Dashboard For June (NYSEARCA:IHE)
Investing 20:21 Bristol Myers Squibb declares quarterly dividend of $0.62 per share
TipRanks 19:20 AbbVie (ABBV) Announces Unsuccessful Phase 3 Trial for Blood Cancer Drug - TipRanks.com
Investing 11:23 BioNTech price target lowered to $138 at H.C. Wainwright
Investing 11:05 I’ll create a factual news article based on the press release in the style of the Wall Street Journal.
Investing 10:58 Prothena partner Roche advances Parkinson’s drug to phase 3
The Motley Fool 08:25 2 Beaten-Down Dividend Stocks to Buy Right Now
Seeking Alpha 12:02 Halozyme Therapeutics: The Waters Become Muddled (NASDAQ:HALO)
Seeking Alpha 14:30 Amgen Stock: Imdelltra Data And Q1 Results Impress (NASDAQ:AMGN)
Investing 11:37 Nuvation Bio stock holds steady as FDA approves lung cancer drug
Benzinga 15:07 BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - CureVac (NASDAQ:CVAC), Novavax (NASDAQ:NVAX)
Reuters 14:00 BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
Investing 14:00 BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
Investing 12:13 Bristol-Myers stock holds steady as Cantor maintains neutral rating
Investing 11:04 Bristol Myers Squibb presents protein degradation data at EHA
Investing 10:56 Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025
Investing 10:14 Applied Therapeutics holds annual stockholders meeting
Seeking Alpha 07:59 Dogs Of The S&P 500 Fetch 11 June 'Safer' Dividend Buys
Seeking Alpha 17:43 Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Investing 11:32 # H.C. Wainwright assumes coverage on ARTIVA stock with buy rating
Investing 11:05 I’ll create a factual news article based on the press release in the style of the Wall Street Journal.

Rango diario

46.72 47.39

Rango anual

39.35 63.16

Cierres anteriores: 46.86
Open: 46.97

Bid: 46.87
Ask: 47.17

Low: 46.72
High: 47.39

Volumen: 25.592 K

Cambio diario: -0.21%
Cambio mensual: -3.38%

Cambio a 6 meses: -17.63%
Cambio anual: 12.56%

23 junio, lunes